| P50 | author | Elliott D. Kieff | Q43399614 |
| P2093 | author name string | M S Kang | |
| | S C Hung | |
| P2860 | cites work | NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells | Q22254088 |
| | Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus | Q24524755 |
| | An Epstein-Barr virus protein interacts with Notch | Q24529019 |
| | Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice | Q24562912 |
| | The cellular proteins that bind specifically to the Epstein-Barr virus origin of plasmid DNA replication belong to a gene family | Q24563778 |
| | Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53 | Q24609153 |
| | Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1. | Q27470145 |
| | The 2.2 A structure of a permanganate-sensitive DNA site bound by the Epstein-Barr virus origin binding protein, EBNA1 | Q27766425 |
| | Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 |
| | GAL4-VP16 is an unusually potent transcriptional activator | Q29616453 |
| | P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. | Q33292267 |
| | Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus | Q33787020 |
| | An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation | Q33825713 |
| | Activator-dependent transcription from chromatin in vitro involving targeted histone acetylation by p300. | Q33921258 |
| | Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1. | Q34107917 |
| | Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 |
| | The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein. | Q35830605 |
| | An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene | Q35838226 |
| | Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2 | Q35852995 |
| | Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line | Q36507642 |
| | Effect of number and position of EBNA-1 binding sites in Epstein-Barr virus oriP on the sites of initiation, barrier formation, and termination of replication | Q36644839 |
| | Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. | Q36682530 |
| | Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA | Q36806138 |
| | Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus. | Q36828339 |
| | A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components | Q36891387 |
| | trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. | Q36899288 |
| | Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter | Q37156071 |
| | Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal | Q37225439 |
| | Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro | Q37608005 |
| | Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptors | Q38340343 |
| | Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428. | Q39549562 |
| | Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus | Q39549892 |
| | Mapping EBNA-1 domains involved in binding to metaphase chromosomes. | Q39550682 |
| | Reconstitution of Epstein-Barr virus-based plasmid partitioning in budding yeast | Q39696990 |
| | Regulation of EBNA gene transcription in lymphoblastoid cell lines: characterization of sequences downstream of BCR2 (Cp). | Q39877574 |
| | Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. | Q39878386 |
| | The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA | Q40067397 |
| | Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis. | Q40139467 |
| | The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell | Q40843575 |
| | Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances | Q40846822 |
| | Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines | Q41172143 |
| | Upstream basal promoter element important for exclusive RNA polymerase III transcription of the EBER 2 gene | Q42133835 |
| | Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. | Q42599854 |
| | Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region | Q44286183 |
| | Persistence of the Entire Epstein-Barr Virus Genome Integrated into Human Lymphocyte DNA | Q45807117 |
| | Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers | Q71195340 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 15233-15238 | |
| P577 | publication date | 2001-12-04 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth | |
| P478 | volume | 98 | |